Literature DB >> 12150892

STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation.

Chien-kuo Lee1, Regina Raz, Ramon Gimeno, Rachel Gertner, Birte Wistinghausen, Kenichi Takeshita, Ronald A DePinho, David E Levy.   

Abstract

STAT3 has been described as an essential component of G-CSF-driven cell proliferation and granulopoiesis. This notion was tested by conditional gene ablation in transgenic mice. Contrary to expectation, granulocytes developed from STAT3 null bone marrow progenitors, and STAT3 null neutrophils displayed mature effector functions. Rather than a deficit in granulopoiesis, mice lacking STAT3 in their hematopoietic progenitors developed neutrophilia, and bone marrow cells were hyperresponsive to G-CSF stimulation. These studies provide direct evidence for STAT3-independent granulopoiesis and suggest that STAT3 directs a negative feedback loop necessary for controlling neutrophil numbers, possibly through induced expression of the signaling inhibitor, SOCS3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150892     DOI: 10.1016/s1074-7613(02)00336-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  104 in total

1.  Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.

Authors:  Xiang-Ping Yang; Kamran Ghoreschi; Scott M Steward-Tharp; Jaime Rodriguez-Canales; Jinfang Zhu; John R Grainger; Kiyoshi Hirahara; Hong-Wei Sun; Lai Wei; Golnaz Vahedi; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Nat Immunol       Date:  2011-01-30       Impact factor: 25.606

2.  Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1.

Authors:  Kiyoshi Hirahara; Kamran Ghoreschi; Xiang-Ping Yang; Hayato Takahashi; Arian Laurence; Golnaz Vahedi; Giuseppe Sciumè; Aisling O'Hara Hall; Christopher D Dupont; Loise M Francisco; Qian Chen; Masao Tanaka; Yuka Kanno; Hong-Wei Sun; Arlene H Sharpe; Christopher A Hunter; John J O'Shea
Journal:  Immunity       Date:  2012-06-21       Impact factor: 31.745

Review 3.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 4.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

5.  Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages.

Authors:  Naohiko Tanaka; Yoshihiko Hoshino; Jeffrey Gold; Satomi Hoshino; Frank Martiniuk; Takeshi Kurata; Richard Pine; David Levy; William N Rom; Michael Weiden
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-13       Impact factor: 6.914

6.  IL-21 mediates suppressive effects via its induction of IL-10.

Authors:  Rosanne Spolski; Hyoung-Pyo Kim; Wei Zhu; David E Levy; Warren J Leonard
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

7.  Restriction of Src activity by Cullin-5.

Authors:  George S Laszlo; Jonathan A Cooper
Journal:  Curr Biol       Date:  2009-01-15       Impact factor: 10.834

8.  Prevention of trauma and hemorrhagic shock-mediated liver apoptosis by activation of stat3alpha.

Authors:  Ana Moran; Ayse Akcan Arikan; Mary-Ann A Mastrangelo; Yong Wu; Bi Yu; Valeria Poli; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2008-06-15

9.  The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis.

Authors:  Akiko Kimura; Michael A Rieger; James M Simone; Weiping Chen; Mark C Wickre; Bing-Mei Zhu; Philipp S Hoppe; John J O'Shea; Timm Schroeder; Lothar Hennighausen
Journal:  Blood       Date:  2009-09-24       Impact factor: 22.113

10.  The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells.

Authors:  Chi-Keung Wan; Jangsuk Oh; Peng Li; Erin E West; Elizabeth A Wong; Allison B Andraski; Rosanne Spolski; Zu-Xi Yu; Jianping He; Brian L Kelsall; Warren J Leonard
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.